Mid-regional pro-adrenomedullin and ST2 in heart failure: Contributions to diagnosis and prognosis
Heart failure has a high prevalence in developed countries. It is a frequent cause of hospital admission and has an important impact on morbidity, mortality and healthcare costs. Biomarkers have been widely studied in heart failure, as they improve diagnosis and prognostic assessment. Natriuretic pe...
Main Authors: | Daniela Lopes, Luiz Menezes Falcão |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-06-01
|
Series: | Revista Portuguesa de Cardiologia |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0870255116302323 |
Similar Items
-
Pro‐adrenomedullin associates with congestion in acute heart failure patients
by: Benedikt N. Beer, et al.
Published: (2024-12-01) -
The association of mid-regional pro-adrenomedullin and mid-regional pro-atrial natriuretic peptide with mortality in an incident dialysis cohort.
by: Ghazaleh Gouya, et al.
Published: (2011-01-01) -
Mid regional pro-adrenomedullin for the prediction of organ failure in infection. Results from a single centre study.
by: Bruno Viaggi, et al.
Published: (2018-01-01) -
Correlation between Serum Mid-Regional Pro-Adrenomedullin and Sequential Organ Failure Assessment (SOFA) Score in Patient with Sepsis
by: Hapsari Pujiyanti, et al.
Published: (2019-06-01) -
Mid-Regional Pro-Adrenomedullin as a Prognostic Factor for Severe COVID-19 ARDS
by: Etienne de Montmollin, et al.
Published: (2022-08-01)